Dow Down0.62% Nasdaq Down1.14%

Antares Pharma Inc. (ATRS)

-NasdaqCM
2.04 0.04(1.92%) Sep 22, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 20,619   22,576   16,458  
Cost of Revenue9,197  9,520  6,797  
Gross Profit 11,421   13,055   9,661  
Operating Expenses
Research Development15,263  14,922  6,699  
Selling General and Administrative17,008  9,585  7,399  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (20,850) (11,451) (4,437)
Income from Continuing Operations
Total Other Income/Expenses Net44  24  49  
Earnings Before Interest And Taxes(20,807)(11,427)(4,388)
Interest Expense -   -   -  
Income Before Tax(20,807)(11,427)(4,388)
Income Tax Expense(300) -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(20,507)(11,427)(4,388)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (20,507) (11,427) (4,388)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (20,507) (11,427) (4,388)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.